Proliferative vitreoretinopathy: Cytologic findings in vitreous samples

Ophthalmic Research

Volumn 35, Issue 4, 2003, Pages 232-238

  Martín, Francisco ^a   Pastor, J Carlos ^a   Rodríguez de la Rúa, Enrique ^a   Mayo Iscar, Agustín ^b   García Arumí, José ^d   Martínez, Vicente ^d   Fernández, Nieves ^c   Saornil, María A ^c  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Stat/Operations Research Department   (Spain)

^c UNIVERSITY OF VALLADOLID   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Proliferative vitreoretinopathy; Rhegmatogenous retinal detachment; Vitreous cytology

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; CELL DENSITY; CELL TYPE; CONTROLLED STUDY; CYTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROSCOPY; MOLECULAR MODEL; PAPANICOLAOU TEST; PRIORITY JOURNAL; RETINA DETACHMENT; VITRECTOMY; VITREORETINOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; FEMALE; FIBROBLASTS; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; RETINAL DETACHMENT; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 0037632750     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071175     Document Type: Article

References (32)

1. Aguirrebeña A, Saornil MA, Giraldo A, Pastor JC: Incidencia de la vitreoretinopatía proliferante (VRP) en el desprendimiento de retina regmatógeno. Arch Soc Esp Oftalmol 1986;51: 229-234.
2. Mietz H, Heimann K: Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal diseases. Br J Ophthalmol 1995;79: 874-877.
3. Morino I, Hiscott P, McKechnie N, Grierson I: Variation in epiretinal membrane components with clinical duration of the proliferative tissue. Br J Ophthalmol 1990;74:393-399.
4. Hiscott PS, Grierson I, McLeod D: Natural history of fibrocellular epiretinal membranes: A quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol 1995;69: 810-823.
5. Yamashita H, Hori S, Masuda K: Population and proportion of component cells in preretinal membranes. Jpn J Ophthalmol 1986;30:269-281.
6. Casaroli R, Vilaró S: The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:2791-2803.
7. Baudouin CH, Hofman P, Brignole F, Bayle J, Loubière R, Gastaud P: Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreo-retinopathy. Ophthalmologica 1991;203:38-46.
8. Coco RM, Martínez J, Ovelar Y, Saornil MA, Pastor JC: Estudio citológico del vítreo en las vitrectomías: Diferencias entre la vitreorretinopatía proliferante y la retinopatía diabética proliferante. Arch Soc Esp Oftalmol 1996;70: 197-204.
9. Toti P, Greco G, Catella AM: Morphological and pathogenetic aspects of proliferative vitreo-retinopathy. A histological and immunohistochemical study. Doc Ophthalmol 1994; 88:105-112.
10. The Retina Society Terminology Committee: The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121-125.
11. Martín F, Pastor JC, Saornil MA, Aragón J, Rodríguez de la Rua E, Bailez C, Miranda I, Fernández N: Comparació n de diferentes técnicas de análisis citológico en muestras vítreas. Arch Soc Esp Oftalmol 2001;76:723-730.
12. Rodríguez de la Rú a E, Martín F, Saornil MA, Fernández N, Pastor JC: Eficacia de la inclusión directa en parafina en el estudio citoló gico del vítreo en pacientes con vitreorretinopatía proliferante (VRP). Arch Soc Esp Oftalmol 2001;76:655-660.
13. Chess J, Sebag J, Tolentino FI, Schepens CL, Calderone JP, Coughlin-Wilkinson E, Albert DM: Pathologic processing of vitrectomy specimens: A comparison of pathologic findings with celloidin bag and cytocentrifugation preparation of 102 vitrectomy specimens. Ophthalmology 1983;90:1560-1564.
14. Pisella PJ, Baudouin C: Les étapes de la prolifération cellulaire dans un modegrave;le expérimental de prolifération vitréorétinienne secondaire à l'injection de plasma enrichi en plaquettes. J Fr Ophtalmol 1996;19:576-584.
15. Yang C-M, Olsen K, Hernández E, Cousins SW: Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy. Graefe's Arch Clin Exp Ophthalmol 1992;230:66-71.
16. Pastor JC: Proliferative vitreoretinopathy: An overview. Surv Ophthalmol 1998;43:3-18.
17. Goldaracena MB, García-Layana A, Pastor JC, Saornil MA, de la Fuente F, Gayoso MJ: The role of retinotomy in an experimental model of proliferative vitreoretinopathy. Curr Eye Res 1997;16:422-427.
18. Sramek SJ, Wallow IH, Stevens TS, Nork TM: Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology 1989;96:835-841.
19. Jerdan JA, Pepose JS, Michels RG, Hayashi H, de Bustros S, Sebag M, Glaser BM: Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 1989; 96:801-810.
20. Cousins S, Rubsamen P: Comparison of flow cytometry with the surgeon regarding ability to predict the ultimate success of surgery for proliferative vitreoretinopathy. Arch Ophthalmol 1994;112:1554-1560.
21. Baudouin Ch, Brignole F, Bayle J, Fred-Reygrobellet D, Lapalus P, Gastaud P: Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1991;32:2065-2072.
22. Baudouin Ch, Khosravi E, Pisella PJ, Ettaiche M, Elena PP: Inflammation measurement and immunocharacterization of cell proliferation in an experimental model of proliferative vitreo-retinopathy. Ophthalmic Res 1998;30:340-350.
23. Wiedemann P: Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992;36:373-384.
24. Esser P, Heimann K, Wiedemann P: Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: Differentiation of subpopulations. Br J Ophthalmol 1993; 77:731-733.
25. Kirmani M, Santana M, Sorgente N, Wiedemann P, Ryan SJ: Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Retina 1983;3:269-272.
26. Wiedemann P, Hilgers RD, Bauer P, Heimann K: Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: Results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 1998;126:550-559.
27. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, Aylward GW: Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy. Results from a randomized, double-blind, controlled clinical trial. Ophthalmology 2001;108:1179-1183.
28. Elner SG, Strieter RM, Elner VM, Rollins BJ, Del Monte MA, Kunkel SL: Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 1991;64:819-825.
29. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG: Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: Immunochemical and in-situ hybridization analyses. Exp Eye Res 1997;65:781-789.
30. Charteris DG, Hiscott P, Robey HL, Gregor ZJ, Lightman SL, Grierson I: Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology 1993;100:43-46.
31. Charteris DG: Proliferative vitreoretinopathy: Pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995;79: 953-960.
32. Casaroli-Marano R, Pagan R, Vilaró S: Epithelial-mesenchymal transition in proliferative vitreoretinopathy: Intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999;40: 2062-2072.